{"rows":[{"id":5979,"title":"Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.","authors":"Eun AC, Yang KH, Palamar JJ","journal":"Psychological medicine","publication_date":"2026-10-06","publication_year":2026,"doi":"10.1017/s0033291726106163","pubmed_id":"42834832","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-10-07 01:20:05","last_checked":"2026-10-07 01:20:05","bibtex":null,"source_record_id":"PMID:42834832","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42834832","source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","doi":"10.1017/s0033291726106163","pmid":"42834832","publication_date":"2026-10-06","importer_version":"2.1.3","text_redistributed":false}},{"id":5963,"title":"Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial","authors":"Bukowski, H.; de Timary, P.; Belahda, D.; Igounenc, N.; Mura, T.; Serrand, C.; Luquiens, A.","journal":"medRxiv","publication_date":"2026-09-29","publication_year":2026,"doi":"10.64898/2026.09.26.26364086","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.26.26364086","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-30 01:20:46","last_checked":"2026-10-06 01:21:04","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.26.26364086","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.26.26364086","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.26.26364086","source_url":"https://doi.org/10.64898/2026.09.26.26364086","doi":"10.64898/2026.09.26.26364086","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5928,"title":"Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.","authors":"Raffa RB.","journal":"Cureus","publication_date":"2026-09-13","publication_year":2026,"doi":"10.7759/cureus.116178","pubmed_id":"42733721","openalex_id":"https://openalex.org/W7212432134","source_url":"https://doi.org/10.7759/cureus.116178","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Review Article,Treatment-Resistant Depression,Drug Interactions,Genomics","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-15 01:20:05","last_checked":"2026-09-20 01:20:21","bibtex":null,"source_record_id":"PMID:42733721","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.7759/cureus.116178","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42733721","source_url":"https://doi.org/10.7759/cureus.116178","doi":"10.7759/cureus.116178","pmid":"42733721","publication_date":"2026-09-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5905,"title":"Patterns of Psychedelic Use in Italy: Insights from the Global Psychedelic Survey","authors":"Beatrice Dal Bianco, Matteo Buonarroti, Alessandro Lo Jacono, Fabio Fesce, Alice Jelmoni, Lucia Cicchi, Andrea Anastasi, Eugenio Rossi, Mauro D'Alonzo, Alessandro Gelao, Caterina Bartoli, Omer Ahmed Syed, Christopher Nicholas, David Luke, Kyle Greenway, Sara Gloeckler, Sara de la Salle, Kobi Bernstein, Allison Feduccia, Alexandre Lehmann, Jacob S. Aday, Stephanie Lake, Daniel Kruger, Philippe Lucas","journal":"Clinical Neuropsychopharmacology and Addiction","publication_date":"2026-09-01","publication_year":2026,"doi":"10.53941/cna.2026.100012","pubmed_id":null,"openalex_id":"https://openalex.org/W7204922957","source_url":"https://doi.org/10.53941/cna.2026.100012","substance_tags":"psilocybin","topic_tags":"Addiction,Microdosing,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"DOI:10.53941/cna.2026.100012","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.53941/cna.2026.100012","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.53941/cna.2026.100012","source_url":"https://doi.org/10.53941/cna.2026.100012","doi":"10.53941/cna.2026.100012","pmid":"","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5884,"title":"Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases","authors":"Sarvi M, Lucas W, Levander X, Sarparast A.","journal":"Research Square","publication_date":"2026-08-26","publication_year":2026,"doi":"10.21203/rs.3.rs-10779254/v2","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10779254/v2","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-08-26 01:20:56","last_checked":"2026-09-02 01:20:31","bibtex":null,"source_record_id":"DOI:10.21203/rs.3.rs-10779254/v2","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.21203/rs.3.rs-10779254/v2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-10779254/v2","source_url":"https://doi.org/10.21203/rs.3.rs-10779254/v2","doi":"10.21203/rs.3.rs-10779254/v2","pmid":"","publication_date":"2026-08-26","importer_version":"2.1.3","text_redistributed":false}},{"id":5879,"title":"Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports.","authors":"Hase A, Erdmann M, Calder A, Limbach V, Erowid E, Erowid F, Hasler G.","journal":"Journal of studies on alcohol and drugs","publication_date":"2026-08-22","publication_year":2026,"doi":"10.15288/jsad.25-00426","pubmed_id":"42631663","openalex_id":"https://openalex.org/W7204005858","source_url":"https://doi.org/10.15288/jsad.25-00426","substance_tags":"psilocybin","topic_tags":"Anxiety,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-24 01:20:04","last_checked":"2026-08-29 01:21:13","bibtex":null,"source_record_id":"PMID:42631663","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.15288/jsad.25-00426","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42631663","source_url":"https://doi.org/10.15288/jsad.25-00426","doi":"10.15288/jsad.25-00426","pmid":"42631663","publication_date":"2026-08-22","importer_version":"2.1.3","text_redistributed":false}},{"id":5867,"title":"Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services","authors":"Korthuis P. Todd, Cook Ryan R., Gregoire Devin, Stauffer Christopher S., Luoma Jason B., Pertl Kellie, Des Jarlais Don, McCarty Dennis, Levander Ximena A., Hoffman Kim A., Wilson-Poe Adrianne R.","journal":"JAMA Network Open","publication_date":"2026-08-19","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.30608","pubmed_id":"42616497","openalex_id":"https://openalex.org/W7203781486","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Wellbeing,Observational Study,Veterans,Healthcare Workers,Safety","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-08-20 01:20:15","last_checked":"2026-08-26 01:20:59","bibtex":null,"source_record_id":"PMID:42616497","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42616497","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","doi":"10.1001/jamanetworkopen.2026.30608","pmid":"42616497","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5865,"title":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.","authors":"Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261473436","pubmed_id":"42609034","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261473436","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-19 01:20:04","last_checked":"2026-08-24 01:20:14","bibtex":null,"source_record_id":"PMID:42609034","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261473436","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42609034","source_url":"https://doi.org/10.1177/02698811261473436","doi":"10.1177/02698811261473436","pmid":"42609034","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5842,"title":"Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics","authors":"Zolali Elmira, McMahon Lance R., Obeng Samuel","journal":"Pharmaceutical Sciences","publication_date":"2026-04-30","publication_year":2026,"doi":"10.34172/ps.026.43663","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.34172/ps.026.43663","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-08-09 08:28:48","last_checked":"2026-08-09 08:28:48","bibtex":null,"source_record_id":"DOI:10.34172/ps.026.43663","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.34172/ps.026.43663","source_url":"https://doi.org/10.34172/ps.026.43663","doi":"10.34172/ps.026.43663","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5835,"title":"Exposure to Potent Hallucinogens in an Adolescent","authors":"Deepak Prabhakar","journal":"The Primary Care Companion For CNS Disorders","publication_date":"2013-10-23","publication_year":2013,"doi":"10.4088/pcc.13l01552","pubmed_id":"24511446","openalex_id":"https://openalex.org/W1965375227","source_url":"http://doi.org/10.4088/pcc.13l01552","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Receptor Pharmacology,Case Report,Adolescents,Safety,Toxicity","study_type":"Case Report","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:54","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"PMID:24511446","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://doi.org/10.4088/pcc.13l01552","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:24511446","source_url":"http://doi.org/10.4088/pcc.13l01552","doi":"10.4088/pcc.13l01552","pmid":"24511446","publication_date":"2013-10-23","importer_version":"2.1.3","text_redistributed":false}},{"id":5832,"title":"Should addiction researchers be interested in psychedelic science?","authors":"Stephen Bright, M.L. Williams, David Caldicott","journal":"Drug and Alcohol Review","publication_date":"2017-04-10","publication_year":2017,"doi":"10.1111/dar.12544","pubmed_id":"28397321","openalex_id":"https://openalex.org/W2606394595","source_url":"https://doi.org/10.1111/dar.12544","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Observational Study,Veterans,Safety,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:52","last_checked":"2026-08-09 08:25:52","bibtex":null,"source_record_id":"PMID:28397321","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1111/dar.12544","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:28397321","source_url":"https://doi.org/10.1111/dar.12544","doi":"10.1111/dar.12544","pmid":"28397321","publication_date":"2017-04-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5822,"title":"Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research","authors":"Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes, Renato Filev","journal":"Addiction Neuroscience","publication_date":"2022-06-22","publication_year":2022,"doi":"10.1016/j.addicn.2022.100025","pubmed_id":null,"openalex_id":"https://openalex.org/W4283324512","source_url":"https://doi.org/10.1016/j.addicn.2022.100025","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Systematic Review,Review Article,Observational Study","study_type":"Systematic Review","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:41","last_checked":"2026-08-09 08:25:41","bibtex":null,"source_record_id":"DOI:10.1016/j.addicn.2022.100025","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.addicn.2022.100025","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.addicn.2022.100025","source_url":"https://doi.org/10.1016/j.addicn.2022.100025","doi":"10.1016/j.addicn.2022.100025","pmid":"","publication_date":"2022-06-22","importer_version":"2.1.3","text_redistributed":false}},{"id":5820,"title":"Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review","authors":"Fabiano F. da Silva, Thaysa Adriane Costa Bernardo, Johny Ricarte das Silva Rodrigues, Pierre Teodósio Félix","journal":"IJS - International Journal of Sciences","publication_date":"2023-01-01","publication_year":2023,"doi":"10.29327/229003.5.3-1","pubmed_id":null,"openalex_id":"https://openalex.org/W4395102419","source_url":"https://doi.org/10.29327/229003.5.3-1","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Chronic Pain,Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:38","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.29327/229003.5.3-1","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.29327/229003.5.3-1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.29327/229003.5.3-1","source_url":"https://doi.org/10.29327/229003.5.3-1","doi":"10.29327/229003.5.3-1","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5819,"title":"The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review","authors":"Kaden Venugopal, Nefissa Bedri","journal":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","publication_date":"2023-01-05","publication_year":2023,"doi":"10.26685/urncst.420","pubmed_id":null,"openalex_id":"https://openalex.org/W4313557238","source_url":"https://doi.org/10.26685/urncst.420","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Microdosing,Spirituality,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:37","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.26685/urncst.420","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.26685/urncst.420","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.26685/urncst.420","source_url":"https://doi.org/10.26685/urncst.420","doi":"10.26685/urncst.420","pmid":"","publication_date":"2023-01-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5798,"title":"Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review","authors":"Ritika Jagdeep Shah, Ashish Sarangi","journal":"Alcoholism Treatment Quarterly","publication_date":"2025-05-02","publication_year":2025,"doi":"10.1080/07347324.2025.2500345","pubmed_id":null,"openalex_id":"https://openalex.org/W4410043539","source_url":"https://doi.org/10.1080/07347324.2025.2500345","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Observational Study,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:20","last_checked":"2026-08-09 08:25:20","bibtex":null,"source_record_id":"DOI:10.1080/07347324.2025.2500345","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1080/07347324.2025.2500345","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/07347324.2025.2500345","source_url":"https://doi.org/10.1080/07347324.2025.2500345","doi":"10.1080/07347324.2025.2500345","pmid":"","publication_date":"2025-05-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5746,"title":"Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease","authors":"National Institute on Aging (NIA)","journal":"ClinicalTrials.gov","publication_date":"2026-10-06","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07721467","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-24 01:25:24","last_checked":"2026-10-07 01:25:08","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07721467","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07721467","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07721467","source_url":"https://clinicaltrials.gov/study/NCT07721467","doi":"","pmid":"","publication_date":"2026-10-06","importer_version":"2.1.3","text_redistributed":false}},{"id":5731,"title":"A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin","authors":"Diamond Therapeutics Inc.","journal":"ClinicalTrials.gov","publication_date":"2026-07-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07710027","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Review Article,Observational Study,Healthy Volunteers,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-18 01:24:24","last_checked":"2026-08-09 10:12:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07710027","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07710027","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07710027","source_url":"https://clinicaltrials.gov/study/NCT07710027","doi":"","pmid":"","publication_date":"2026-07-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5727,"title":"Sex-dependent effects of psychedelics: review of evidence from rodent models.","authors":"Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K","journal":"Frontiers in psychiatry","publication_date":"2026-01-01","publication_year":2026,"doi":"10.3389/fpsyt.2026.1824073","pubmed_id":"42528876","openalex_id":"https://openalex.org/W7168359165","source_url":"https://pubmed.ncbi.nlm.nih.gov/42528876/","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-17 01:20:14","last_checked":"2026-08-09 08:27:45","bibtex":null,"source_record_id":"PMID:42528876","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42528876/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42528876","source_url":"https://pubmed.ncbi.nlm.nih.gov/42528876/","doi":"10.3389/fpsyt.2026.1824073","pmid":"42528876","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5718,"title":"National bill seeks to jump-start psychedelic treatment for veterans","authors":"Gary Enos","journal":"Alcoholism & Drug Abuse Weekly","publication_date":"2026-07-11","publication_year":2026,"doi":"10.1002/adaw.34973","pubmed_id":null,"openalex_id":"https://openalex.org/W7168096739","source_url":"https://doi.org/10.1002/adaw.34973","substance_tags":"psilocybin","topic_tags":"PTSD,Clinical Trial,Veterans","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-14 01:20:14","last_checked":"2026-08-09 08:25:00","bibtex":null,"source_record_id":"DOI:10.1002/adaw.34973","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/adaw.34973","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/adaw.34973","source_url":"https://doi.org/10.1002/adaw.34973","doi":"10.1002/adaw.34973","pmid":"","publication_date":"2026-07-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5328,"title":"GAMBARAN KARAKTERISTIK SOSIODEMOGRAFIK, TINGKAT PENGETAHUAN DAN POLA PENGGUNAAN JAMUR Psilocybin PADA MAHASISWA S1 UNIVERSITAS PADJAJARAN PERIODE AJAR2010-2011","authors":"Natasha Amalda Ediwan","journal":"Universitas Padjadjaran Repository","publication_date":"2012-01-01","publication_year":2012,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W3203535261","source_url":"https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252","substance_tags":"psilocybin","topic_tags":"General","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252","source_url":"https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252","doi":"","pmid":"","publication_date":"2012-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":356,"page":1,"per_page":20,"pages":18,"resource":"papers","filters":{"q":"alcohol","author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}